<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Option Backdating at UnitedHealth (BAV, Wednesday, Week 9)</title>
    <meta name="description" content="I am writing about my experiences as a naval navel-gazer.">
    <link rel="stylesheet" href="/css/index.css">
    <link rel="stylesheet" href="/css/prism-base16-monokai.dark.css">
    <link rel="alternate" href="/feed/feed.xml" type="application/atom+xml" title="Colin Barry">
    <link rel="alternate" href="/feed/feed.json" type="application/json" title="Colin Barry">
    <link rel="icon" type="image/x-icon" href="/img/favicon.ico">
  </head>
  <body>
    <header>
      <h1 class="home"><a href="/">Colin Barry</a></h1>
      <ul class="nav">
        <li class="nav-item"><a href="/">Home</a></li>
        <li class="nav-item"><a href="/pages/about/">About</a></li>
        <li class="nav-item"><a href="/pages/contact/">Contact</a></li>
        <li class="nav-item"><a href="/posts/">Archive</a></li>
      </ul>
    </header>

    <main class="tmpl-post">

      <h1>Option Backdating at UnitedHealth (BAV, Wednesday, Week 9)</h1>

<time datetime="2012-03-28">28 Mar 2012</time><a href="/tags/business-analysis-and-valuation/" class="post-tag">business-analysis-and-valuation</a><a href="/tags/year-two/" class="post-tag">year-two</a>

<p>CEO compensation for Bill McGuire:<br>
-- &quot;extraordinary&quot; =&gt; cash salary/bonus = $45M, options = $300M<br>
-- BUT he built UnitedHealth. Market cap has grown by a factor of 50 under his tenure (1991-2005); shareholders overwhelmingly approve of him and his compensation package.</p>
<p>How to account for stock options? Fair value.<br>
Intrinsic value:<br>
-- Expense = 0 (non-cash charge)<br>
-- Footnote on annual report<br>
-- Appears as dilution.</p>
<p>Fair value:<br>
-- Comparability between firms<br>
-- Matching principal (&quot;cost&quot; of options spread over vesting period)<br>
-- Use options pricing methodology (Black Scholes) to value options at issuance</p>
<p>To other huge problem: backdating.<br>
Retroactive choice of grant date =&gt; greater dilution for shareholders, greater moral hazard<br>
Is it illegal? No, not if it's transparent --- just issuing options at below-market strike price...<br>
Another controversial trend: &quot;spring loading&quot; =&gt; timing options issuance to immediately precede good news</p>
<p>Is this a big deal for UnitedHealth? Should it impact valuation?<br>
Market cap declines by $20B. Impact of backdating: maybe $400M.<br>
Maybe fundamentals unaffected, but:<br>
Management distraction from lawsuit, SEC investigation, trust in management/board (worse because UnitedHealth is an insurer), possible departure of high-performing CEO, political pressure, etc.<br>
A fine mess...</p>

<hr>
<ul><li>Next: <a href="/posts/vietnam-national-economic-strategy-moc-tuesday-week-9/">Vietnam / National Economic Strategy (MOC, Tuesday, Week 9)</a></li><li>Previous: <a href="/posts/linkedin-csn-wednesday-week-9/">LinkedIn (CSN, Wednesday, Week 9)</a></li>
</ul>

    </main>

    <footer></footer>

    <!-- Current page: /posts/option-backdating-at-unitedhealth-bav-wednesday-week-9/ -->
  </body>
</html>
